Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2164852

CC(Nc1ncnc2[nH]cnc12)c1ccc2cccnc2c1-c1ccccc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 8/20 0.48
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
DYRK1A Q13627 1/20 0.36
PIK3CG P48736 6/20 0.35
PIK3R2 O00459 1/20 0.35
AURKA O14965 1/20 0.35
RPS6KB1 P23443 1/20 0.35
AURKB Q96GD4 1/20 0.35
PIK3CA P42336 5/20 0.34
PIK3CB P42338 4/20 0.34
UBE2N P61088 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 2/20 0.34
P4HB P07237 2/20 0.34
MAPT P10636 2/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
GNRHR P30968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016174 0.92 PIK3CD (0.54) PIK3CDDYRK1APIK3CGPIK3R2PIK3CA
Trifluoroacetic Acid SCHEMBL2164086 0.87 PIK3CD (0.58) PIK3CDPIK3CGRPS6KB1PIK3CAPIK3CB
Trifluoroacetic Acid SCHEMBL2163739 0.86 PIK3CD (0.51) PIK3CDDYRK1APIK3CGPIK3R2L3MBTL1
Trifluoroacetic Acid SCHEMBL2166431 0.85 PIK3CD (0.68) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R1
Trifluoroacetic Acid SCHEMBL2165358 0.84 PIK3CD (0.55) PIK3CDPIK3CGPIK3CAPIK3CBUBE2N
SCHEMBL2017399 0.78 PIK3CD (0.66) PIK3CDDYRK1APIK3CGPIK3CAPIK3CB
Trifluoroacetic Acid SCHEMBL2163712 0.78 PIK3CD (0.53) PIK3CDPIK3CGAURKARPS6KB1AURKB
SCHEMBL2011285 0.77 PIK3CD (0.57) PIK3CDDYRK1APIK3CGPIK3R2L3MBTL1
Trifluoroacetic Acid SCHEMBL2164027 0.77 PIK3CD (0.43) PIK3CDPIK3CGAURKARPS6KB1AURKB
SCHEMBL2016212 0.77 PIK3CD (0.77) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS PIK3R1, PIK3R3, PIK3R2 PIK3CD 13/4885ADORA2A 1513/4885ADORA1 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.